UNIVERSITY OF WASHINGTON

44.4% of eligible infants included in neonatal trial results; parents declining (29.8%) or not approached (9.3%) major reasons for noninclusion. Modifiable factors account for most noninclusions, highlighting recruitment challenges and need for improved trial documentation.

A UW-led study in Nature Communications suggests rocky planets orbiting M-dwarfs, like TRAPPIST-1's, can develop stable atmospheres over time, enhancing the chances for life. The James Webb Space Telescope has observed that the hottest planets near TRAPPIST-1 lack significant atmospheres, but has not yet characterized those in the 'Goldilocks zone,' where conditions might support liquid water and life.

Lixte Biotechnology Holdings, Inc. schedules its 2024 Annual Meeting of Stockholders for December 19, 2024, to vote on the election of five director nominees, ratification of Weinberg & Company, P.A. as the independent registered public accounting firm, and approval of executive officer compensation. The meeting will be virtual, accessible via a live webcast.

A wearable camera system using AI detects medication errors with 99.6% sensitivity and 98.8% specificity, potentially enhancing patient safety in clinical settings.

Vivian Shi, MD, discusses creative eczema management approaches, including natural oils, massage therapy, and music therapy, emphasizing holistic care. Combination therapies like biologics with immunosuppressants show promise. The future of eczema treatment will involve personalized medicine and multi-targeted therapies. Clinicians should engage patients with realistic, adaptable goals and affordable treatment plans. For resistant cases, personalized action plans and lifestyle changes are crucial. Managing eczema with comorbidities requires a collaborative approach with specialists. Mental health and patient well-being are integral to effective eczema management.

At the 2024 AAO meeting, Cecilia S. Lee, M.D., M.S., and Aaron Y. Lee, M.D., M.S.C.I., debated AI's role in healthcare, with Cecilia advocating for AI's potential to enhance individual-focused care and research, while Aaron cautioned against over-reliance, emphasizing human judgment's importance.

Evvy appoints Dr. Kate McLean as its first Chief Medical Officer, focusing on expanding patient offerings, uncovering new biomarkers, and building strategic partnerships. Dr. McLean brings extensive experience in women’s health, spanning clinical practice, public health, and digital health innovation.

A University of Michigan-led study found that modafinil and cognitive behavioral therapy (CBT) significantly reduce fatigue in MS patients, with no added benefit from combining both treatments. Published in The Lancet Neurology, the research highlights the comparable effectiveness of CBT and modafinil for MS fatigue, emphasizing the importance of patient-centered treatment decisions.

Fred Hutchinson Cancer Center researchers, led by Dr. Julie McElrath, developed a new HIV vaccine formulation combining 3M-052-AF adjuvant with HIV Env trimers, inducing neutralizing antibodies in human trials. This marks a new vaccine platform needing optimization for broadly neutralizing antibodies against circulating HIV strains.

The Nobel Prize in chemistry was awarded to scientists who used AlphaFold, an AI program, to predict protein folding patterns, potentially revolutionizing drug discovery. Immunai, a biotech company, aims to map the immune system using AI, enhancing drug development. Schrödinger, a physics-based software company, applies mathematical constants to molecular structures for drug discovery, emphasizing the need for both computational and experimental approaches.